| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3258 | 2011 |
| Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial SS Jolly, S Yusuf, J Cairns, K Niemelä, D Xavier, P Widimsky, A Budaj, ... The Lancet 377 (9775), 1409-1420, 2011 | 2463 | 2011 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes. S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ... The New England journal of medicine 354 (14), 1464-1476, 2006 | 1457 | 2006 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … S Yusuf, K Teo, C Anderson, J Pogue, L Dyal, I Copland, H Schumacher, ... Lancet 372 (9644), 1174-1183, 2008 | 1190 | 2008 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, R Afzal, J Pogue, CB Granger, ... JAMA: the journal of the American Medical Association 295 (13), 1519-1530, 2006 | 1155 | 2006 |
| Early versus delayed invasive intervention in acute coronary syndromes SR Mehta, CB Granger, WE Boden, PG Steg, JP Bassand, DP Faxon, ... New England Journal of Medicine 360 (21), 2165-2175, 2009 | 1060 | 2009 |
| Dose comparisons of clopidogrel and aspirin in acute coronary syndromes SR Mehta, JP Bassand, S Chrolavicius, R Diaz, JW Eikelboom, KA Fox, ... N Engl J Med 363 (10), 930-942, 2010 | 995 | 2010 |
| Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study SD Anker, A Negassa, AJS Coats, R Afzal, PA Poole-Wilson, JN Cohn, ... The Lancet 361 (9363), 1077-1083, 2003 | 874 | 2003 |
| Dronedarone in high-risk permanent atrial fibrillation SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ... New England Journal of Medicine 365 (24), 2268-2276, 2011 | 792 | 2011 |
| Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionResults From the OASIS-5 Trial SR Mehta, CB Granger, JW Eikelboom, JP Bassand, L Wallentin, ... Journal of the American College of Cardiology 50 (18), 1742-1751, 2007 | 346 | 2007 |
| Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes A Budaj, JW Eikelboom, SR Mehta, R Afzal, S Chrolavicius, JP Bassand, ... European heart journal 30 (6), 655-661, 2009 | 258 | 2009 |
| Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction R Díaz, A Goyal, SR Mehta, R Afzal, D Xavier, P Pais, S Chrolavicius, ... JAMA: the journal of the American Medical Association 298 (20), 2399-2405, 2007 | 232 | 2007 |
| Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux PG Steg, SS Jolly, SR Mehta, R Afzal, D Xavier, HJ Rupprecht, ... JAMA: The Journal of the American Medical Association 304 (12), 1339-1349, 2010 | 182 | 2010 |
| Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction A Goyal, SR Mehta, R Díaz, HC Gerstein, R Afzal, D Xavier, L Liu, P Pais, ... Circulation 120 (24), 2429-2437, 2009 | 171 | 2009 |
| AVERROES Steering Committee and investigators SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... Apixaban in patients with atrial fibrillation. N Engl J Med 364 (9), 806-817, 2011 | 161 | 2011 |
| Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non–ST-segment elevation acute coronary syndromes KAA Fox, JP Bassand, SR Mehta, L Wallentin, P Theroux, LS Piegas, ... Annals of internal medicine 147 (5), 304-310, 2007 | 156 | 2007 |
| Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Arixtra Study in … SR Mehta, PG Steg, CB Granger, JP Bassand, DP Faxon, JI Weitz, R Afzal, ... Circulation 111 (11), 1390-1397, 2005 | 155 | 2005 |
| The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial RJG Peters, C Joyner, JP Bassand, R Afzal, S Chrolavicius, SR Mehta, ... European heart journal 29 (3), 324-331, 2008 | 134 | 2008 |
| Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST-and Non–ST-Segment Elevation Acute Coronary Syndromes An … SR Mehta, WE Boden, JW Eikelboom, M Flather, PG Steg, A Avezum, ... Circulation 118 (20), 2038-2046, 2008 | 118 | 2008 |
| Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes JP Bassand, R Afzal, J Eikelboom, L Wallentin, R Peters, A Budaj, ... European heart journal 31 (1), 50-58, 2010 | 117 | 2010 |
